Tenet Healthcare (THC) EBITDA (2009 - 2026)

Tenet Healthcare (THC) has 18 years of EBITDA data on file, last reported at $1.3 billion in Q1 2026.

• Quarterly EBITDA rose 37.43% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 billion (up 6.83% YoY) and the FY2025 annual result came in at $4.2 billion, down 36.31% from the prior year.
• EBITDA rose to $1.3 billion in Q1 2026 per THC's latest filing, from $853.0 million in the prior quarter.
• The five-year high for EBITDA was $3.3 billion in Q1 2024, with the low at $536.0 million in Q4 2022.
• Average EBITDA over 5 years is $917.8 million, with a median of $761.0 million recorded in 2024.
• Year-over-year, EBITDA jumped 444.78% in 2024 and plunged 71.29% in 2025.
• Tenet Healthcare's EBITDA stood at $536.0 million in 2022, then jumped by 37.13% to $735.0 million in 2023, then advanced by 11.7% to $821.0 million in 2024, then grew by 3.9% to $853.0 million in 2025, then jumped by 51.93% to $1.3 billion in 2026.
• Business Quant data shows THC's EBITDA at $1.3 billion in Q1 2026, $853.0 million in Q4 2025, and $889.0 million in Q3 2025.